ESC 365 - In vitro and in vivo genome engineering of Dilated Cardiomyopathy caused by phospholamban R14 deletion.

Open Access

In vitro and in vivo genome engineering of Dilated Cardiomyopathy caused by phospholamban R14 deletion.

Session: Moderated Poster session - Genetic, Epigenetic & Integrative

Topic: Gene therapy

Speaker: Doctor F. Stillitano (Utrecht, NL)

Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

Add to my library

About the speaker

Doctor Francesca Stillitano

University Medical Center Utrecht, Utrecht (Netherlands (The))

2 presentations

0 follower

6 more presentations in this session

Inhibiting mitochondrial fission with Mdivi-1 directs cardiac differentiation of human induced pluripotent stem cells via protein kinase CK2

Speaker: Doctor S. Lim (Melbourne, AU)

A novel role of tristetraprolin in preventing mitochondrial dysfunction in the heart against iron deficiency by optimizing expression of Rieske iron-sulfur protein

Speaker: Doctor T. Sato (Chicago, US)

Different therapeutic approaches to downregulate the activation of the hepatic interleukin-6/stat3/complement pathway in two models of autoimmune myocarditis

Speaker: Doctor F. Marino (Turin, IT)

Contractile dysfunction of induced pluripotent stem cell-derived cardiomyocytes from a duchenne muscular dystrophy patient

Speaker: Doctor J. Pioner (Florence, IT)

Cigarette smoking increases expression of the G protein-coupled receptor 15 mRNA by change in CpG methylation

Speaker: Ms T. Haase (Hamburg, DE)

Access the full session

Moderated Poster session - Genetic, Epigenetic & Integrative

Speakers: Doctor F. Stillitano, Doctor S. Lim, Doctor T. Sato, Doctor F. Marino, Doctor J. Pioner...

About the event

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources